News & Updates

Upgrade Subscription

20 December 2024

Acquisitions Industry News Investments Production

Reckitt Benckiser Group Acquires North Carolina OTC Facility

Reckitt Benckiser Group (Reckitt) has acquired a pharmaceutical site in Wilson, NC, that will expand its U.S. manufacturing footprint and enable it to produce Mucinex tablets and liquids to meet increased consumer demand for cold and flu symptom relief in the United States.

Reckitt will invest £155 million ($200 million) in the site to establish a manufacturing facility, which is intended to ensure a more resilient supply chain in the U.S. Located in the vicinity of the ‘Research Triangle’, the Wilson factory will become Reckitt’s biggest over-the-counter (OTC) manufacturing facility in the U.S. and is expected to create nearly 300 jobs.

Get started today.

PharmaChem Investor is your all-in-one solution for making strategic decisions, and driving innovation in the dynamic world of pharmaceuticals.

We notice you're using a small screen...

PharmaChem Investor is designed and optimised best for desktop devices and large screens, to make the most of all of the data available. We recommend accessing the site on a desktop device.

Logout